Lymphocyte infiltration predicts survival in chemotherapy-naive, triple-negative breast cancer and identifies patients with intrinsically good prognosis: have we been bringing owls to Athens?

Dubsky, P; Montagna, G; Ritter, M

Dubsky, P; Montagna, G; Ritter, M.

Afiliação

Dubsky P; Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Breast Center, Hirslanden Klinik St Anna, Lucerne. Electronic address: peter.dubsky@hirslanden.ch.
Montagna G; Breast Center, University Hospital of Basel, Basel, Switzerland; Department of Surgery, Memorial Sloan Kettering Cancer Center, Breast Service, New York, USA.
Ritter M; Breast Center, University Hospital of Basel, Basel, Switzerland.

Ann Oncol ; 30(12): 1849-1850, 2019 12 01.

Article em En | MEDLINE | ID: mdl-31626275

Assuntos

Neoplasias da Mama; Estrigiformes; Neoplasias de Mama Triplo Negativas; Animais; Biomarcadores Tumorais; Quimioterapia Adjuvante; Humanos; Linfócitos do Interstício Tumoral; Prognóstico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Estrigiformes / Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Ann Oncol Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google